MSC Therapy for Osteoarthritis: An Unfinished Story
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Mesenchymal stromal cells (MSCs) have firmly occupied the attention of orthopedic clinicians and scientists for most of the last 25 years. Hundreds of laboratories worldwide have carried out research aimed at unraveling the biological characteristics of these cells and probing the manner in which they potentially contribute to cartilage and bone repair. Clinical trials registries indicate that they are also being tested in patient studies for a wide range of conditions such as osteoarthritis, rheumatoid arthritis, fracture repair, regeneration of articular cartilage, tendon repair, and for treatment of degenerative disc disease. Despite these efforts, the effectiveness of MSCs as a treatment modality for these conditions is still uncertain and market authorizations have been limited. In addition, critical and clear phenotypic parameters for defining MSCs are uncertain and a coherent biological framework surrounding the therapeutic mechanism of action is not yet available. Added to this, cell manufacturing protocols are complex and costly and present substantial challenges in terms of regulatory oversight and standardization. Despite these obstacles, MSCs still remain at the forefront of efforts in Regenerative Medicine, based on a conviction that this technology can provide an effective treatment paradigm for major diseases where there is still an unmet need. © 2019 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 37:1229–1235, 2019.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities
Galipeau, J., & Sensébé, L. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.05.004 · Cited by 1,819
Zhang, S., Chuah, S. J., Lai, R. C., Hui, J. H. P., Lim, S. K., & Toh, W. S. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2017.11.028 · Cited by 919
de Witte, S. F. H., Luk, F., Sierra Parraga, J. M., Gargesha, M., Merino, A., Korevaar, S. S., Shankar, A. S., O'Flynn, L., Elliman, S. J., Roy, D., et al. (2018) · Stem Cells · doi:10.1002/stem.2779 · Cited by 504
Extracellular vesicles in renal tissue damage and regeneration
Bruno, S., Porta, S., & Bussolati, B. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.06.058 · Cited by 74 · cited 2×
“In an important study, Bruno et al.(36) showed that EVs obtained from human MSCs had a potent therapeutic effect in a mouse model of acute kidney injury by exerting proliferative and anti‐apoptotic effects on tubular endothelial cells and by transferring their messenger RNA content to the target cells.”
Background
Cited by
Liang, Y., Xu, X., Li, X., Xiong, J., Li, B., Duan, L., Wang, D., & Xia, J. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c10458 · Cited by 391
Giorgino, R., Albano, D., Fusco, S., Peretti, G. M., Mangiavini, L., & Messina, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076405 · Cited by 387
Mesenchymal Stromal Cells for Aging Cartilage Regeneration: A Review
Wu, K.-C., Chang, Y.-H., Ding, D.-C., & Lin, S.-Z. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312911 · Cited by 33
“While both adipose-derived and bone marrow-derived MSCs have been studied, their effectiveness remains uncertain [211].”
Needle to needle robot‐assisted manufacture of cell therapy products
Ochs, J., Hanga, M. P., Shaw, G., Duffy, N., Kulik, M., Tissin, N., Reibert, D., Biermann, F., Moutsatsou, P., Ratnayake, S., et al. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10387 · Cited by 18
“Current production systems mainly involve laboratory-scale manual processing using flasks or cell factories and the dispersed nature of such manufacturing is associated with exceptionally poor process standardization.(4) Critical process parameters including cell source, media composition, seeding density, passage num…”
BackgroundSelf-citation
Metadata
- Authors
- Barry, F.
- Venue
- Journal of Orthopaedic Research
- Publisher
- Wiley
- Published
- 2019-05-23
- Volume
- 37
- Issue
- 6
- Pages
- 1229-1235
- ISSN
- 0736-0266 (ISSN-L)
- 1554-527X
- OpenAlex
- W2945736579
- Cited by
- 100
- References
- 4
- FWCI
- 5.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: MSC Therapy for Osteoarthritis: An Unfinished Story. https://app.cochat.ai/papers/10.1002/jor.24343
- The paper
- Barry, F. (2019). MSC Therapy for Osteoarthritis: An Unfinished Story. Journal of Orthopaedic Research. https://doi.org/10.1002/jor.24343
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.